Price at ₹796 is 15% below 200 SMA, confirming long-term downtrend.
Governance review found no major lapses, clearing path for CEO reappointment.
Governance review found no major lapses, clearing CEO reappointment path.
P/E (TTM) at 17.42x, below 5-year average; forward P/E compelling at 12.41x.
50-day SMA is ₹138 below 200-day SMA at ₹934.42.
Valuation at 17.4x TTM is below historical 20-25x range.
MACD at -7.07, recovery from deeply oversold to merely oversold.
Stop-loss tightened to ₹760 (2x ATR) from ₹745, aligned with ₹771-773 support.